RANK Signaling Amplifies WNT-Responsive Mammary Progenitors through R-SPONDIN1

Stem Cell Reports

Volumn 5, Issue 1, 2015, Pages 31-44

  Joshi, Purna A ^a   Waterhouse, Paul D ^a   Kannan, Nagarajan ^b   Narala, Swami ^a   Fang, Hui ^a   Di Grappa, Marco A ^a   Jackson, Hartland W ^a   Penninger, Josef M ^c   Eaves, Connie ^b   Khokha, Rama ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; PLASMA PROTEIN; PROGESTERONE; R SPONDIN1 PROTEIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; UNCLASSIFIED DRUG; WNT PROTEIN; RSPO1 PROTEIN, MOUSE; THROMBOSPONDIN; TNFRSF11A PROTEIN, MOUSE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASAL CELL; BREAST CELL; BREAST EPITHELIUM CELL; BREAST PROGENITOR CELL; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUTEAL PHASE; MENSTRUAL CYCLE; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN DEPLETION; SIGNAL TRANSDUCTION; STEM CELL; STEM CELL EXPANSION; WNT SIGNALING PATHWAY; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL PROLIFERATION; CYTOLOGY; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; UDDER;

ANIMALS; CELL PROLIFERATION; FEMALE; HUMANS; MAMMARY GLANDS, ANIMAL; MICE; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; STEM CELLS; THROMBOSPONDINS; WNT SIGNALING PATHWAY;

EID: 84937527027     PISSN: 22136711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.stemcr.2015.05.012     Document Type: Article

References (46)

1. M.L. Asselin-Labat, K.D. Sutherland, H. Barker, R. Thomas, M. Shackleton, N.C. Forrest, L. Hartley, L. Robb, F.G. Grosveld, J. van der Wees, and et al. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation Nat. Cell Biol. 9 2007 201 209
2. M.L. Asselin-Labat, F. Vaillant, J.M. Sheridan, B. Pal, D. Wu, E.R. Simpson, H. Yasuda, G.K. Smyth, T.J. Martin, G.J. Lindeman, and J.E. Visvader Control of mammary stem cell function by steroid hormone signalling Nature 465 2010 798 802
3. M. Beleut, R.D. Rajaram, M. Caikovski, A. Ayyanan, D. Germano, Y. Choi, P. Schneider, and C. Brisken Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland Proc. Natl. Acad. Sci. USA 107 2010 2989 2994
4. V. Beral Million Women Study Collaborators Breast cancer and hormone-replacement therapy in the Million Women Study Lancet 362 2003 419 427
5. C. Brisken, A. Heineman, T. Chavarria, B. Elenbaas, J. Tan, S.K. Dey, J.A. McMahon, A.P. McMahon, and R.A. Weinberg Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling Genes Dev. 14 2000 650 654
6. C. Cai, Q.C. Yu, W. Jiang, W. Liu, W. Song, H. Yu, L. Zhang, Y. Yang, and Y.A. Zeng R-spondin1 is a novel hormone mediator for mammary stem cell self-renewal Genes Dev. 28 2014 2205 2218
7. R.D. Cardiff, and S.R. Wellings The comparative pathology of human and mouse mammary glands J. Mammary Gland Biol. Neoplasia 4 1999 105 122
8. S. Chadi, L. Buscara, C. Pechoux, J. Costa, J. Laubier, M.C. Chaboissier, E. Pailhoux, J.L. Vilotte, E. Chanat, and F. Le Provost R-spondin1 is required for normal epithelial morphogenesis during mammary gland development Biochem. Biophys. Res. Commun. 390 2009 1040 1043
9. R.T. Chlebowski, T.E. Rohan, J.E. Manson, A.K. Aragaki, A. Kaunitz, M.L. Stefanick, M.S. Simon, K.C. Johnson, J. Wactawski-Wende, M.J. O'Sullivan, and et al. Breast cancer after use of estrogen plus progestin and estrogen alone. Analyses of data from 2 women's health initiative randomized clinical trials JAMA Oncol. 2015 10.1001/jamaoncol.2015.0494 Published online April 16, 2015
10. W. de Lau, W.C. Peng, P. Gros, and H. Clevers The R-spondin/Lgr5/Rnf43 module: regulator of Wnt signal strength Genes Dev. 28 2014 305 316
11. P. Eirew, J. Stingl, A. Raouf, G. Turashvili, S. Aparicio, J.T. Emerman, and C.J. Eaves A method for quantifying normal human mammary epithelial stem cells with in vivo regenerative ability Nat. Med. 14 2008 1384 1389
12. J.E. Fata, Y.Y. Kong, J. Li, T. Sasaki, J. Irie-Sasaki, R.A. Moorehead, R. Elliott, S. Scully, E.B. Voura, D.L. Lacey, and et al. The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development Cell 103 2000 41 50
13. R. Fernandez-Valdivia, A. Mukherjee, Y. Ying, J. Li, M. Paquet, F.J. DeMayo, and J.P. Lydon The RANKL signaling axis is sufficient to elicit ductal side-branching and alveologenesis in the mammary gland of the virgin mouse Dev. Biol. 328 2009 127 139
14. F.C. Geyer, M. Lacroix-Triki, K. Savage, M. Arnedos, M.B. Lambros, A. MacKay, R. Natrajan, and J.S. Reis-Filho β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation Mod. Pathol. 24 2011 209 231
15. J.D. Graham, P.A. Mote, U. Salagame, J.H. van Dijk, R.L. Balleine, L.I. Huschtscha, R.R. Reddel, and C.L. Clarke DNA replication licensing and progenitor numbers are increased by progesterone in normal human breast Endocrinology 150 2009 3318 3326
16. P.A. Joshi, H.W. Jackson, A.G. Beristain, M.A. Di Grappa, P.A. Mote, C.L. Clarke, J. Stingl, P.D. Waterhouse, and R. Khokha Progesterone induces adult mammary stem cell expansion Nature 465 2010 803 807
17. P.A. Joshi, M.A. Di Grappa, and R. Khokha Active allies: hormones, stem cells and the niche in adult mammopoiesis Trends Endocrinol. Metab. 23 2012 299 309
18. P.A. Joshi, P.J. Goodwin, and R. Khokha Progesterone exposure and breast cancer risk. Understanding the biological roots JAMA Oncol. 2015 10.1001/jamaoncol.2015.0512 Published online April 16, 2015
19. N. Kannan, N. Huda, L. Tu, R. Droumeva, G. Aubert, E. Chavez, R.R. Brinkman, P. Lansdorp, J. Emerman, S. Abe, and et al. The luminal progenitor compartment of the normal human mammary gland constitutes a unique site of telomere dysfunction Stem Cell Rev. 1 2013 28 37
20. N. Kannan, L.V. Nguyen, M. Makarem, Y. Dong, K. Shih, P. Eirew, A. Raouf, J.T. Emerman, and C.J. Eaves Glutathione-dependent and -independent oxidative stress-control mechanisms distinguish normal human mammary epithelial cell subsets Proc. Natl. Acad. Sci. USA 111 2014 7789 7794
21. J.L. Kelsey, M.D. Gammon, and E.M. John Reproductive factors and breast cancer Epidemiol. Rev. 15 1993 36 47
22. Y.C. Kim, R.J. Clark, F. Pelegri, and C.M. Alexander Wnt4 is not sufficient to induce lobuloalveolar mammary development BMC Dev. Biol. 9 2009 55
23. H.J. Lee, D. Gallego-Ortega, A. Ledger, D. Schramek, P. Joshi, M.M. Szwarc, C. Cho, J.P. Lydon, R. Khokha, J.M. Penninger, and C.J. Ormandy Progesterone drives mammary secretory differentiation via RankL-mediated induction of Elf5 in luminal progenitor cells Development 140 2013 1397 1401
24. E. Lim, F. Vaillant, D. Wu, N.C. Forrest, B. Pal, A.H. Hart, M.L. Asselin-Labat, D.E. Gyorki, T. Ward, A. Partanen kConFab Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers Nat. Med. 15 2009 907 913
25. S.Y. Lin, W. Xia, J.C. Wang, K.Y. Kwong, B. Spohn, Y. Wen, R.G. Pestell, and M.C. Hung Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression Proc. Natl. Acad. Sci. USA 97 2000 4262 4266
26. X. Liu, G.W. Robinson, K.U. Wagner, L. Garrett, A. Wynshaw-Boris, and L. Hennighausen Stat5a is mandatory for adult mammary gland development and lactogenesis Genes Dev. 11 1997 179 186
27. M. Makarem, N. Kannan, L.V. Nguyen, D.J. Knapp, S. Balani, M.D. Prater, J. Stingl, A. Raouf, O. Nemirovsky, P. Eirew, and C.J. Eaves Developmental changes in the in vitro activated regenerative activity of primitive mammary epithelial cells PLoS Biol. 11 2013 e1001630
28. G. Molyneux, F.C. Geyer, F.A. Magnay, A. McCarthy, H. Kendrick, R. Natrajan, A. Mackay, A. Grigoriadis, A. Tutt, A. Ashworth, and et al. BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells Cell Stem Cell 7 2010 403 417
29. R. Nusse, C. Fuerer, W. Ching, K. Harnish, C. Logan, A. Zeng, D. ten Berge, and Y. Kalani Wnt signaling and stem cell control Cold Spring Harb. Symp. Quant. Biol. 73 2008 59 66
30. P. Pellegrini, A. Cordero, M.I. Gallego, W.C. Dougall, M. Purificación, M.A. Pujana, and E. Gonzalez-Suarez Constitutive activation of RANK disrupts mammary cell fate leading to tumorigenesis Stem Cells 31 2013 1954 1965
31. R.D. Rajaram, D. Buric, M. Caikovski, A. Ayyanan, J. Rougemont, J. Shan, S.J. Vainio, O. Yalcin-Ozuysal, and C. Brisken Progesterone and Wnt4 control mammary stem cells via myoepithelial crosstalk EMBO J. 34 2015 641 652
32. R. Ramakrishnan, S.A. Khan, and S. Badve Morphological changes in breast tissue with menstrual cycle Mod. Pathol. 15 2002 1348 1356
33. J.E. Rossouw, G.L. Anderson, R.L. Prentice, A.Z. LaCroix, C. Kooperberg, M.L. Stefanick, R.D. Jackson, S.A. Beresford, B.V. Howard, K.C. Johnson, and et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial JAMA 288 2002 321 333
34. A. Ryo, M. Nakamura, G. Wulf, Y.C. Liou, and K.P. Lu Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC Nat. Cell Biol. 3 2001 793 801
35. D. Santini, G. Schiavon, B. Vincenzi, L. Gaeta, F. Pantano, A. Russo, C. Ortega, C. Porta, S. Galluzzo, G. Armento, and et al. Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients PLoS ONE 6 2011 e19234
36. D. Schramek, A. Leibbrandt, V. Sigl, L. Kenner, J.A. Pospisilik, H.J. Lee, R. Hanada, P.A. Joshi, A. Aliprantis, L. Glimcher, and et al. Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer Nature 468 2010 98 102
37. M. Shehata, A. Teschendorff, G. Sharp, N. Novcic, I.A. Russell, S. Avril, M. Prater, P. Eirew, C. Caldas, C.J. Watson, and J. Stingl Phenotypic and functional characterisation of the luminal cell hierarchy of the mammary gland Breast Cancer Res. 14 2012 R134
38. Y.J. Shiah, P. Tharmapalan, A.E. Casey, P.A. Joshi, T.D. McKee, H.W. Jackson, A.G. Beristain, M.A. Chan-Seng-Yue, G.D. Bader, J.P. Lydon, and et al. A progesterone-CXCR4 axis controls mammary progenitor cell fate in the adult gland Stem Cell Rev. 4 2015 313 322
39. K.E. Sleeman, H. Kendrick, D. Robertson, C.M. Isacke, A. Ashworth, and M.J. Smalley Dissociation of estrogen receptor expression and in vivo stem cell activity in the mammary gland J. Cell Biol. 176 2007 19 26
40. J. Stingl, P. Eirew, I. Ricketson, M. Shackleton, F. Vaillant, D. Choi, H.I. Li, and C.J. Eaves Purification and unique properties of mammary epithelial stem cells Nature 439 2006 993 997
41. A.T. Stopeck, A. Lipton, J.J. Body, G.G. Steger, K. Tonkin, R.H. de Boer, M. Lichinitser, Y. Fujiwara, D.A. Yardley, M. Viniegra, and et al. Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study J. Clin. Oncol. 28 2010 5132 5139
42. T. Tanos, G. Sflomos, P.C. Echeverria, A. Ayyanan, M. Gutierrez, J.F. Delaloye, W. Raffoul, M. Fiche, W. Dougall, P. Schneider, and et al. Progesterone/RANKL is a major regulatory axis in the human breast Science Trans. Med. 5 2013 182ra155
43. R. van Amerongen, A.N. Bowman, and R. Nusse Developmental stage and time dictate the fate of Wnt/β-catenin-responsive stem cells in the mammary gland Cell Stem Cell 11 2012 387 400
44. A. Van Keymeulen, A.S. Rocha, M. Ousset, B. Beck, G. Bouvencourt, J. Rock, N. Sharma, S. Dekoninck, and C. Blanpain Distinct stem cells contribute to mammary gland development and maintenance Nature 479 2011 189 193
45. M. Widschwendter, A.N. Rosenthal, S. Philpott, I. Rizzuto, L. Fraser, J. Hayward, M.P. Intermaggio, C.K. Edlund, S.J. Ramus, S.A. Gayther, and et al. The sex hormone system in carriers of BRCA1/2 mutations: a case-control study Lancet Oncol. 14 2013 1226 1232
46. Y.A. Zeng, and R. Nusse Wnt proteins are self-renewal factors for mammary stem cells and promote their long-term expansion in culture Cell Stem Cell 6 2010 568 577